|Partial Close, 4/2009 ||$150k|
|Partial Close, 9/2010 ||$250k|
|Partial Close, 3/2012 ||$50k|
|Series D, 10/2012 ||$4M|
HemoShear creates human relevant systems to accurately replicate the biology of organ systems and diseases for use throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful human response data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. Their science leads to new medicines and improves human health.